These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30782980)

  • 1. Lipid-related genetic polymorphisms significantly modulate the association between lipids and disability progression in multiple sclerosis.
    Zhang Y; Zhou Y; van der Mei IAF; Simpson S; Ponsonby AL; Lucas RM; Tettey P; Charlesworth J; Kostner K; Taylor BV;
    J Neurol Neurosurg Psychiatry; 2019 Jun; 90(6):636-641. PubMed ID: 30782980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
    Pan G; Simpson S; van der Mei I; Charlesworth JC; Lucas R; Ponsonby AL; Zhou Y; Wu F; Taylor BV
    J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1204-1211. PubMed ID: 27559181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An adverse lipid profile is associated with disability and progression in disability, in people with MS.
    Tettey P; Simpson S; Taylor B; Blizzard L; Ponsonby AL; Dwyer T; Kostner K; van der Mei I
    Mult Scler; 2014 Nov; 20(13):1737-44. PubMed ID: 24829292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event.
    Tettey P; Simpson S; Taylor B; Ponsonby AL; Lucas RM; Dwyer T; Kostner K; ; van der Mei IA
    J Neurol Neurosurg Psychiatry; 2017 May; 88(5):395-401. PubMed ID: 28320766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis.
    Weinstock-Guttman B; Zivadinov R; Ramanathan M
    J Neurol Sci; 2011 Dec; 311(1-2):86-91. PubMed ID: 21849177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis.
    Weinstock-Guttman B; Zivadinov R; Mahfooz N; Carl E; Drake A; Schneider J; Teter B; Hussein S; Mehta B; Weiskopf M; Durfee J; Bergsland N; Ramanathan M
    J Neuroinflammation; 2011 Oct; 8():127. PubMed ID: 21970791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis.
    Cocozza S; Pontillo G; Lanzillo R; Russo C; Petracca M; Di Stasi M; Paolella C; Vola EA; Criscuolo C; Moccia M; Lamberti A; Monti S; Brescia Morra V; Elefante A; Palma G; Tedeschi E; Brunetti A
    Neuroradiology; 2019 Feb; 61(2):155-162. PubMed ID: 30617409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body Composition in Multiple Sclerosis Patients and Its Relationship to the Disability Level, Disease Duration and Glucocorticoid Therapy.
    Matusik E; Durmala J; Ksciuk B; Matusik P
    Nutrients; 2022 Oct; 14(20):. PubMed ID: 36296931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.
    Yin RX; Wu DF; Miao L; Htet Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
    Biofactors; 2013; 39(3):315-25. PubMed ID: 23355348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApaI, BsmI and TaqI VDR gene polymorphisms in association with multiple sclerosis in Slovaks.
    Čierny D; Michalik J; Škereňová M; Kantorová E; Sivák Š; Javor J; Kurča E; Dobrota D; Lehotský J
    Neurol Res; 2016 Aug; 38(8):678-84. PubMed ID: 27338176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor 7-like 2 single nucleotide polymorphisms are associated with lipid profile in the Balinese.
    Oktavianthi S; Saraswati MR; Suastika K; Dwipayana P; Sulfianti A; Hayati RF; Trimarsanto H; Febinia CA; Sudoyo H; Malik SG
    Mol Biol Rep; 2018 Oct; 45(5):1135-1143. PubMed ID: 30027476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arylsulfatase a gene polymorphisms in relapsing remitting multiple sclerosis: genotype-phenotype correlation and estimation of disease progression.
    Baronica KB; Mlinac K; Ozretić D; Vladić A; Bognar SK
    Coll Antropol; 2011 Jan; 35 Suppl 1():11-6. PubMed ID: 21648305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of apolipoprotein E gene polymorphisms with blood lipids and their interaction with dietary factors.
    Shatwan IM; Winther KH; Ellahi B; Elwood P; Ben-Shlomo Y; Givens I; Rayman MP; Lovegrove JA; Vimaleswaran KS
    Lipids Health Dis; 2018 Apr; 17(1):98. PubMed ID: 29712557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis.
    Wesnes K; Myhr KM; Riise T; Kvistad SS; Torkildsen Ø; Wergeland S; Holmøy T; Midgard R; Bru A; Edland A; Eikeland R; Gosal S; Harbo HF; Kleveland G; Sørenes YS; Øksendal N; Bjørnevik K
    Mult Scler Relat Disord; 2021 May; 50():102801. PubMed ID: 33636616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
    Yadav V; Marracci G; Kim E; Spain R; Cameron M; Overs S; Riddehough A; Li DK; McDougall J; Lovera J; Murchison C; Bourdette D
    Mult Scler Relat Disord; 2016 Sep; 9():80-90. PubMed ID: 27645350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disability in multiple sclerosis is associated with age and inflammatory, metabolic and oxidative/nitrosative stress biomarkers: results of multivariate and machine learning procedures.
    Flauzino T; Simão ANC; de Carvalho Jennings Pereira WL; Alfieri DF; Oliveira SR; Kallaur AP; Lozovoy MAB; Kaimen-Maciel DR; Maes M; Reiche EMV
    Metab Brain Dis; 2019 Oct; 34(5):1401-1413. PubMed ID: 31302813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Five VDR Polymorphisms on Multiple Sclerosis Risk and Progression: a Case-Control and Genotype-Phenotype Study.
    Křenek P; Benešová Y; Bienertová-Vašků J; Vašků A
    J Mol Neurosci; 2018 Apr; 64(4):559-566. PubMed ID: 29589202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common genetic variation within miR-146a predicts disease onset and relapse in multiple sclerosis.
    Zhou Y; Chen M; Simpson S; Lucas RM; Charlesworth JC; Blackburn N; van der Mei I; Ponsonby AL; ; Taylor BV
    Neurol Sci; 2018 Feb; 39(2):297-304. PubMed ID: 29127522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
    Fitzgerald KC; Munger KL; Köchert K; Arnason BG; Comi G; Cook S; Goodin DS; Filippi M; Hartung HP; Jeffery DR; O'Connor P; Suarez G; Sandbrink R; Kappos L; Pohl C; Ascherio A
    JAMA Neurol; 2015 Dec; 72(12):1458-65. PubMed ID: 26458124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.